COMPARISON OF HYPOMETHYLATING AGENTS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME: RETROSPECTIVE ANALYSIS, SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Unal, A. [1 ]
Keni, N. [1 ]
Yildizhan, E. [1 ]
Turak, E. [1 ]
Kaynar, L. [1 ]
Zararsiz, G. [1 ]
Uysal, E. [1 ]
Eser, B. [1 ]
Cetin, M. [1 ]
机构：
[1] Erciyes Univ, Dept Hematol, Kayseri, Turkey
来源：
LEUKEMIA RESEARCH | 2017年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP-22
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [41] Survival Advantage with Hypomethylating Agents In Patients with Higher Risk Myelodysplastic Syndrome
    Park, Young-Hoon
    Lee, Je-Hwan
    Lee, Kyoo Hyung
    Lee, Jung-Hee
    Kim, Dae-Young
    Kim, Sung-Doo
    Lim, Sung-Nam
    Choi, Yunsuk
    Seol, Mice
    Lee, Young-Shin
    Kang, Young-A
    Jeon, Mijin
    BLOOD, 2010, 116 (21) : 775 - 775
  • [42] INTENSIVE TREATMENT OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME: A SINGLE CENTER EXPERIENCE
    Crotta, A.
    Tassara, M.
    Messina, C.
    Malato, S.
    Ciceri, F.
    Bernardi, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 551 - 552
  • [43] Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective casecontrol study
    Jabbour, Elias
    Mathisen, Michael S.
    Garcia-Manero, Guillermo
    Champlin, Richard
    Popat, Uday
    Khouri, Issa
    Giralt, Sergio
    Kadia, Tapan
    Chen, Julianne
    Pierce, Sherry
    Koca, Ebru
    Daver, Naval
    Tanaka, Maria
    Rondon, Gabriela
    Oran, Betul
    Parmar, Simrit
    Kantarjian, Hagop
    de Lima, Marcos
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (03) : 198 - 200
  • [44] Treatment of cholangiocarcinoma: Retrospective analysis of a single-center experience.
    Gaudig, Ina
    Schwoerer, Harald
    Ramadori, Giuliano
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [45] Hypomethylating agents vs. Allogeneic sct in elderly patients with advanced myelodysplastic syndromes: A single center study
    Cermak, J.
    Vitek, A.
    Markova-Stastna, M.
    Soukupova-Maaloufova, J.
    Cetkovsky, P.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S477 - S477
  • [46] ANALYSIS OF RESPONSE TO ERYTHROPOIETIN-STIMULATING AGENTS (ESAs) IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS), EXPERIENCE OF A CENTER
    Jimenez, M.
    Molero, A.
    Saumell, S.
    Montoro, J.
    Merchan, B.
    Raheja, P.
    Varela, A.
    Perez, A.
    Gallur, L.
    Tazon, B.
    Ortega, M.
    Rodriguez, S.
    Bosch, F.
    Valcarcel, D.
    HAEMATOLOGICA, 2018, 103 : 183 - 183
  • [47] Chemotherapy Versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome Following Allogeneic Stem Cell Transplant: A Retrospective Review
    Motabi, Ibraheem H.
    Liu, Jingxia
    Abboud, Camille N.
    Cashen, Amanda F.
    Stockler-Goldstein, Keith E.
    Uy, Geoffrey L.
    Vij, Ravi
    Westervelt, Peter
    DiPersio, John F.
    BLOOD, 2014, 124 (21)
  • [48] Unraveling the Somatic Mutational Landscape in Myelodysplastic Syndrome: A Single Center Experience
    Dey, I.
    Vinarkar, S.
    Parihar, M.
    Patel, K.
    Demde, R.
    Saha, K.
    Banerjee, S.
    Nathi, D.
    Nag, A.
    Kumar, J.
    Nair, R.
    Chandy, M.
    Mishra, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S41 - S41
  • [49] Venetoclax combined with hypomethylating agents for favorable risk acute myeloid leukemia: A single center experience
    Bajwa, Shammas
    Parkin, Brian
    Gayle, Arlene A.
    Patel, Rushang D.
    Mori, Shahram
    Pancari, Philip
    Socola, Francisco Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents
    Festuccia, Moreno
    Baker, Kelsey
    Gooley, Theodore A.
    Sandmaier, Brenda M.
    Deeg, H. Joachim
    Scott, Bart L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1509 - 1514
12345